652 related articles for article (PubMed ID: 7948129)
1. Retroviral vectors containing chimeric promoter/enhancer elements exhibit cell-type-specific gene expression.
Couture LA; Mullen CA; Morgan RA
Hum Gene Ther; 1994 Jun; 5(6):667-77. PubMed ID: 7948129
[TBL] [Abstract][Full Text] [Related]
2. Retroviral vector with a CMV-IE/HIV-TAR hybrid LTR gives high basal expression levels and is up-regulated by HIV-1 Tat.
Robinson D; Elliott JF; Chang LJ
Gene Ther; 1995 Jun; 2(4):269-78. PubMed ID: 7552987
[TBL] [Abstract][Full Text] [Related]
3. Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors.
Freas-Lutz DL; Correll PH; Dougherty SF; Xu L; Pluznik DH; Karlsson S
Exp Hematol; 1994 Aug; 22(9):857-65. PubMed ID: 8062885
[TBL] [Abstract][Full Text] [Related]
4. Retroviral vectors for high-level transgene expression in T lymphocytes.
Engels B; Cam H; Schüler T; Indraccolo S; Gladow M; Baum C; Blankenstein T; Uckert W
Hum Gene Ther; 2003 Aug; 14(12):1155-68. PubMed ID: 12908967
[TBL] [Abstract][Full Text] [Related]
5. Retroviral vectors containing putative internal ribosome entry sites: development of a polycistronic gene transfer system and applications to human gene therapy.
Morgan RA; Couture L; Elroy-Stein O; Ragheb J; Moss B; Anderson WF
Nucleic Acids Res; 1992 Mar; 20(6):1293-9. PubMed ID: 1313966
[TBL] [Abstract][Full Text] [Related]
6. Efficient gene transfer by hybrid retroviral vectors to murine spermatogenic cells.
Danno S; Itoh K; Baum C; Ostertag W; Ohnishi N; Kido T; Tomiwa K; Matsuda T; Fujita J
Hum Gene Ther; 1999 Jul; 10(11):1819-31. PubMed ID: 10446922
[TBL] [Abstract][Full Text] [Related]
7. Insertion of two independent enhancers in the long terminal repeat of a self-inactivating vector results in high-titer retroviral vectors with tissue-specific expression.
Fassati A; Bardoni A; Sironi M; Wells DJ; Bresolin N; Scarlato G; Hatanaka M; Yamaoka S; Dickson G
Hum Gene Ther; 1998 Nov; 9(17):2459-68. PubMed ID: 9853513
[TBL] [Abstract][Full Text] [Related]
8. Development of improved adenosine deaminase retroviral vectors.
Onodera M; Nelson DM; Yachie A; Jagadeesh GJ; Bunnell BA; Morgan RA; Blaese RM
J Virol; 1998 Mar; 72(3):1769-74. PubMed ID: 9499026
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human immunodeficiency virus type-1 by retroviral vectors expressing antisense-TAR.
Chuah MK; VandenDriessche T; Chang HK; Ensoli B; Morgan RA
Hum Gene Ther; 1994 Dec; 5(12):1467-75. PubMed ID: 7711139
[TBL] [Abstract][Full Text] [Related]
11. High frequency expression of integrated proviruses derived from enhancer trap retroviruses.
Sablitzky F; Jönsson JI; Cohen BL; Phillips RA
Cell Growth Differ; 1993 Jun; 4(6):451-9. PubMed ID: 8373730
[TBL] [Abstract][Full Text] [Related]
12. Increase in nitrosourea resistance in mammalian cells by retrovirally mediated gene transfer of bacterial O6-alkylguanine-DNA alkyltransferase.
Dumenco LL; Warman B; Hatzoglou M; Lim IK; Abboud SL; Gerson SL
Cancer Res; 1989 Nov; 49(21):6044-51. PubMed ID: 2676154
[TBL] [Abstract][Full Text] [Related]
13. Efficient gene transfer and expression in primary B lymphocytes.
Overell RW; Weisser KE; Hess BW; Ziegler SF; Pleiman CM; Maliszewski C; Grabstein KH
J Immunol Methods; 1991 Jul; 141(1):53-62. PubMed ID: 1865123
[TBL] [Abstract][Full Text] [Related]
14. Expression from leukocyte integrin promoters in retroviral vectors.
Bauer TR; Osborne WR; Kwok WW; Hickstein DD
Hum Gene Ther; 1994 Jun; 5(6):709-16. PubMed ID: 7948133
[TBL] [Abstract][Full Text] [Related]
15. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.
Baum C; Hegewisch-Becker S; Eckert HG; Stocking C; Ostertag W
J Virol; 1995 Dec; 69(12):7541-7. PubMed ID: 7494260
[TBL] [Abstract][Full Text] [Related]
16. Tissue-specific gene expression from Mo-MLV retroviral vectors with hybrid LTRs containing the murine tyrosinase enhancer/promoter.
Vile RG; Diaz RM; Miller N; Mitchell S; Tuszyanski A; Russell SJ
Virology; 1995 Dec; 214(1):307-13. PubMed ID: 8525635
[TBL] [Abstract][Full Text] [Related]
17. Insertion of the human cytomegalovirus enhancer into a myeloproliferative sarcoma virus long terminal repeat creates a high-expression retroviral vector.
van den Wollenberg DJ; Hoeben RC; van Ormondt H; van der Eb AJ
Gene; 1994 Jul; 144(2):237-41. PubMed ID: 8039708
[TBL] [Abstract][Full Text] [Related]
18. T cell-specific expression from Mo-MLV retroviral vectors containing a CD4 mini-promoter/enhancer.
Zhao-Emonet JC; Marodon G; Pioche-Durieu C; Cosset FL; Klatzmann D
J Gene Med; 2000; 2(6):416-25. PubMed ID: 11199262
[TBL] [Abstract][Full Text] [Related]
19. Engineered long terminal repeats of retroviral vectors enhance transgene expression in hepatocytes in vitro and in vivo.
Yamaguchi K; Itoh K; Ohnishi N; Itoh Y; Baum C; Tsuji T; Nagao T; Higashitsuji H; Okanoue T; Fujita J
Mol Ther; 2003 Nov; 8(5):796-803. PubMed ID: 14599813
[TBL] [Abstract][Full Text] [Related]
20. Promoter choice for retroviral vectors: transcriptional strength versus trans-activation potential.
Weber EL; Cannon PM
Hum Gene Ther; 2007 Sep; 18(9):849-60. PubMed ID: 17767401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
